Company Overview - Agilent Technologies, Inc. is a leading company in laboratory instrumentation, software, services, and consumables, serving the life-sciences, diagnostics, and applied chemical markets with a market cap of $41.6 billion [1] Earnings Expectations - Analysts expect Agilent Technologies to report a profit of $1.59 per share on a diluted basis for the fiscal fourth quarter, representing an 8.9% increase from $1.46 per share in the same quarter last year [2] - For the current fiscal year, analysts anticipate an EPS of $5.58, up 5.5% from $5.29 in fiscal 2024, and a further increase to $5.98 in fiscal 2026, reflecting a year-over-year growth of approximately 7.2% [3] Stock Performance - Agilent's shares have increased by 12.6% over the past year, which is below the S&P 500's 18.4% gains but significantly outperforms the Health Care Select Sector SPDR Fund's 1.5% decline during the same period [4] - The upward trend in Agilent's share price is attributed to solid earnings beats, positive guidance, and increased investor confidence, with a reported revenue growth of 10.1% year-over-year in Q3 2025 [5] Analyst Ratings - The consensus opinion among analysts is bullish, with a "Moderate Buy" rating overall; nine out of 16 analysts recommend a "Strong Buy," while the remaining seven suggest a "Hold" [6] - The average analyst price target for Agilent is $151.92, indicating a potential upside of 3.6% from current levels [6]